Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatitis C Viral”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT00881582
What this trial is testing

Peginterferon Alfa-2a Plus Ribavirin Combination Treatment in Chronic Hepatitis C Post-Renal Transplant Patients

Who this might be right for
Chronic Hepatitis CRenal Transplant
King Abdulaziz Medical City 32
Testing effectiveness (Phase 2)Study completedNCT02886624
What this trial is testing

Short Duration Therapy of Acute Hepatitis C Genotypes 1 or 4

Who this might be right for
Acute Hepatitis CHIV
Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba 30
Large-scale testing (Phase 3)Study completedNCT02609659
What this trial is testing

Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With Low-Dose Ribavirin QD in Subjects With Genotype 1a Chronic Hepatitis C Virus Infection

Who this might be right for
Hepatitis C Virus (HCV)
AbbVie 105
Post-approval studies (Phase 4)Study completedNCT00560274
What this trial is testing

NeoRecormon (Epoetin Beta) in Anemic Patients With Chronic Hepatitis C.

Who this might be right for
Anemia
Hoffmann-La Roche 190
Early research (Phase 1)Study completedNCT01438320
What this trial is testing

Q-Trial in Patients With Hepatitis C

Who this might be right for
Chronic Hepatitis C
University of California, Los Angeles 34
Testing effectiveness (Phase 2)Study completedNCT00277238
What this trial is testing

CPG10101 Combination Therapy For The Treatment Of Hepatitis C In Non-Responder (Null And Partial Responder) Hepatitis C Virus (HCV) Genotype 1 Infected Subjects

Who this might be right for
Hepatitis, Chronic Active
Pfizer 113
Not applicableStudy completedNCT03132389
What this trial is testing

Prevalence of Sexually Transmitted Infections Among People Attending the Sexual Assault Centre in Oslo, Norway.

Who this might be right for
Sexual Assault and RapeSexually Transmitted Diseases
University of Oslo 640
Post-approval studies (Phase 4)Study completedNCT00087568
What this trial is testing

PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With Ribavirin in Patients With Chronic Hepatitis C (CHC) Previously Treated With PEG-Intron + Ribavirin

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 57
Not applicableWithdrawnNCT04395118
What this trial is testing

STOP HCC: Mailed HCV Treatment Outreach Program for HCC Prevention for Elevated LFTs

Who this might be right for
Hepatitis CHepatocellular Carcinoma
University of Texas Southwestern Medical Center
Testing effectiveness (Phase 2)Study completedNCT01436357
What this trial is testing

Staged Phase I/II Hepatitis C Prophylactic Vaccine

Who this might be right for
Hepatitis C
National Institute of Allergy and Infectious Diseases (NIAID) 548
Testing effectiveness (Phase 2)Study completedNCT01074008
What this trial is testing

Study to Evaluate the Safety, Tolerability and Antiviral Activity of ABT-450, ABT-333 and ABT-072

Who this might be right for
Hepatitis CHCVChronic Hepatitis C Infection+1 more
AbbVie (prior sponsor, Abbott) 74
Early research (Phase 1)Study completedNCT02128217
What this trial is testing

Sofosbuvir-Containing Regimens Without Interferon For Treatment of Acute Hepatitis C Virus (HCV) Infection

Who this might be right for
HIV-1 InfectionHepatitis
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections 44
Not applicableUnknownNCT04768517
What this trial is testing

HCV Reinfection in in HIV/HCV-coinfected Patients Achieving SVR by Antiviral Therapy

Who this might be right for
Hepatitis C Virus InfectionHepatitis C Virus Infection, Response to Therapy ofHuman Immunodeficiency Virus (HIV) Coinfection
National Taiwan University Hospital 300
Testing effectiveness (Phase 2)Study completedNCT01180790
What this trial is testing

Safety, Tolerability, and Antiviral Activity of ACH-0141625 or Placebo in Combination With Peginterferon and Ribavirin in Hepatitis C Virus (HCV) Positive Participants

Who this might be right for
Hepatitis C
Alexion Pharmaceuticals, Inc. 122
Not applicableStudy completedNCT03594838
What this trial is testing

Evaluation of HCV Viremia Testing Approaches Among PWID in Georgia

Who this might be right for
Hepatitis C, Chronic
Foundation for Innovative New Diagnostics, Switzerland 1,672
Early research (Phase 1)Study completedNCT00393276
What this trial is testing

Determining Responses to Two Different Vaccines in HIV and HCV Infected Individuals

Who this might be right for
HIV InfectionsHepatitis C
National Institute of Allergy and Infectious Diseases (NIAID) 29
Testing effectiveness (Phase 2)Study completedNCT02468648
What this trial is testing

Viral Kinetics, Interferon Stimulated Genes (ISGs) and mirRNA Among Subjects Infected With Different Hepatitis C Virus Genotypes During Therapy With Sofosbuvir and GS-5816

Who this might be right for
Chronic Hepatitis C
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 72
Not applicableStudy completedNCT05568576
What this trial is testing

Metabolic Syndrome and Long-term Survival Following Liver Resection

Who this might be right for
Survival
Assiut University 70
Not applicableEnded earlyNCT02590068
What this trial is testing

Effects of Chronic Viral Infection on Immune Response to Zoster Vaccination

Who this might be right for
Hepatitis C
Rockefeller University 14
Early research (Phase 1)WithdrawnNCT00255359
What this trial is testing

Safety, Tolerability and Efficacy of XTL 2125 in HCV-Infected Patients Who Are Interferon-Alpha Non-Responders or Relapsers

Who this might be right for
Chronic Hepatitis C Virus Infection
Hadassah Medical Organization 60
Next Page